About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Evaluation of the QuantiFERON CMV Assay

NCT03502161·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

QIAGEN Gaithersburg, Inc

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adult CMV D+/R- liver, kidney, heart, pancreas, lung, intestinal, or combined transplant recipients that are 18 years of age or older.
Scheduled to receive between 3 to 6 months of antiviral prophylaxis
Provide Informed Consent

You may not be if

Subjects less than 18 years old
Scheduled to receive longer than 6 months or shorter than 3 months of prophylaxis
Unable to provide Informed Consent

The record

StatusTerminated

PhaseNo phase

Taking part8

StartedNov 2018

UpdatedSep 16, 2020

Conditions

Where1

University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States

Clareo Health | Clinical Evaluation of the QuantiFERON CMV Assay